Post-License Safety Evaluation of Influenza Virus Vaccine

Clinical Trial of Quadrivalent Influenza Virus Split Vaccine in Population Aged 3-8 Years

NCT05138705 ·Status: COMPLETED ·Phase: PHASE4

Safety and Immunogenicity Study of Split Influenza Virus Vaccine in Different Age Groups

NCT01654809 ·Status: COMPLETED ·Phase: PHASE4

Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2007/2008) When Administered to Elderly Subjects

NCT00522236 ·Status: COMPLETED ·Phase: PHASE2

Clinical Trial to Evaluate the Protective Efficacy and Safety of a Nasal Spray Live Attenuated Influenza Vaccine (LAIV) in Adults Aged 18-59 Years Post-Vaccination

NCT07133802 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

A Clinical Trial of an Quadrivalent Inactivated Influenza Vaccine in Healthy Children Aged 6 to 35 Months

NCT05212623 ·Status: COMPLETED ·Phase: PHASE1

The Safety and Immunogenicity Evaluation of Live Attenuated Influenza Vaccine

NCT05056519 ·Status: UNKNOWN ·Phase: PHASE1

Immunogenicity and Safety Study of a GSK Influenza Vaccine Candidate in Adults.

NCT00714285 ·Status: COMPLETED ·Phase: PHASE1

Safety Study of Quadrivalent Subunit Influenza Vaccine in People Aged 3 Years and Older

NCT07332689 ·Status: COMPLETED

The Safety and Immunogenicity Evaluation of Live Attenuated Influenza Vaccine

NCT05284851 ·Status: UNKNOWN ·Phase: PHASE2

Safety Study of CSL Limited's Influenza Virus Vaccine in the Paediatric Population Aged >= 6 Months to < 18 Years

NCT00825162 ·Status: COMPLETED ·Phase: PHASE4

Phase Ⅱ Clinical Trial of Influenza Virus Split Vaccine for Individuals Aged 60 Years and Above

NCT07327398 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Phase IV Clinical Trial of an Influenza Split Vaccine Anflu

NCT00556062 ·Status: COMPLETED ·Phase: PHASE4

The Clinical Trial Protocol for the Influenza Virus Vaccine (Split Virion, Inactivated)

NCT01551810 ·Status: COMPLETED ·Phase: PHASE3

The Clinical Trial Protocol for the Influenza Virus Vaccine (Split Virion, Inactivated) （Children Forms of Drug）

NCT01551823 ·Status: COMPLETED ·Phase: PHASE3

Safety, Tolerability, and Immunogenicity Study of a Cell-based Virosomal Influenza Vaccine in Healthy Adults

NCT02148328 ·Status: COMPLETED ·Phase: PHASE1

Clinical Trial of Quadrivalent Influenza Virus Split Vaccine

NCT04363359 ·Status: COMPLETED ·Phase: PHASE2

Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Subjects 18 Years of Age or Older

NCT00329966 ·Status: COMPLETED ·Phase: PHASE2

A Phase I Trial to Evaluate the Safety and Immunogenicity of Influenza Virus Split Vaccine (Adjuvant)

NCT07349017 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

Immunogenicity and Safety of a Vaccine Against Influenza (2010-2011 Northern Hemisphere Season, Intradermal Route)

NCT01138397 ·Status: COMPLETED ·Phase: PHASE3

Immunogenicity and Safety Study of an Investigational Influenza (H1N1 Influenza Virus) Vaccine in Adults

NCT00989287 ·Status: COMPLETED ·Phase: PHASE3

Clinical Study for Safety and Immunogenicity Study of Influenza Vaccine

NCT01617239 ·Status: COMPLETED ·Phase: PHASE1

Efficacy Study of Two Influenza Vaccines and Placebo in Healthy Adult Subjects

NCT00630331 ·Status: COMPLETED ·Phase: PHASE3

Evaluate the Safety and Efficacy of Quadrivalent Influenza in Real-world Situations.

NCT06334510 ·Status: COMPLETED

Safety and Immunogenicity of the Butantan Quadrivalent Influenza Vaccine

NCT03927131 ·Status: COMPLETED ·Phase: PHASE3

Safety and Immunogenicity of the Butantan Institute Influenza Vaccine Compared to Sanofi Pasteur Influenza Vaccine

NCT03777163 ·Status: COMPLETED ·Phase: PHASE4